ASP8951, Sodium Chloride 0.9% Intravenous Infusion BP
8951-CL-0301
Phase 3 small_molecule active
Quick answer
ASP8951, Sodium Chloride 0.9% Intravenous Infusion BP for Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma is a Phase 3 program (small_molecule) at Astellas Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Astellas Pharma GmbH
- Indication
- Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active